1) Model for end-stage liver disease
MELD
1.
Objective: To investigate the clinical value of MELD (model for end-stage liver disease) score for evaluation of perioperative nutrition status liver transplantation candidates.
目的:探讨MELD评分(终末期肝病模型)在评价行肝移植手术患者围手术期营养状况中的应用价值。
2.
To compare predictive capability among model for end-stage liver disease, Cox proportional hazard model and back-propagation neural network.
Cox比例风险模型与BP神经网络在肝移植受体预后分析中的应用 目的:探讨肝移植受体预后的影响因素,比较MELD模型、Cox比例风险模型及BP神经网络对肝移植受体预后的预测性能;利用BP神经网络预测肝移植受体的生存期,为生存期的预测提供新的思路。
2) MELD scoring system
MELD评分
1.
MELD scoring system and prognosis in patients with decompensated liver cirrhosis;
失代偿期肝硬化患者的MELD评分与预后
2.
Methods: The clinical data of 250 severe hepatitis were collected andevaluated by MELD scoring system to evaluate the severe hepatitispatient s condition and prognosis ; and comp.
目的:由于国内外重型肝炎诊断存在差异,故引入终末期肝病评估模式,通过对250例重型肝炎临床资料进行MELD评分,评估病情严重程度与预后,以验证MELD评分系统在国内适用性。
3) MELD score
MELD评分
1.
Pretransplantation MELD score predicts short-term survival of patients with benign end-stage liver disease post-liver transplantation;
MELD评分预测良性终末期肝病肝移植术后短期生存率的初步研究
2.
The study about pretransplantation MELD score in predicting short-term survival of patients with end-stage liver disease post liver transplantation;
MELD评分预测终末期肝病肝移植术后短期生存率的研究
3.
Methods By calculating MELD score of 23 patients with viral hepatic cirrhosis and 19 normal controls before operation and evaluating quantitative values of fibrosis of liver specimens after operation using computer-assisted digital image analysis,correlation among MELD score and Child-Turcotte-Pugh classification and the percentage of hepatic fibro.
方法对19例正常对照组和23例肝炎后肝硬化肝病组病人术前测定MELD评分,同时采用计算机辅助数字图像分析法检测正常对照组和肝病组病人肝组织标本的纤维化程度,分析肝纤维化定量评估与Child-Pugh分级及MELD评分间的关系。
4) MELD classification
MELD分级
5) MELD
[英][meld] [美][mɛld]
MELD评分
1.
Preoperative Characteristics of Patients with Different MELD Scores and Effects of MELD Scores on Regulating Circulation in Liver Transplantation
不同MELD评分患者术前临床特征及MELD评分对肝移植术中循环调控的影响
2.
To compare the capability of the logistic model, model for end-stage liver disease (MELD) and Child-Turcotte-Pugh (CTP) in predicting the prognosis of patients using receiver operating characteristic (ROC) curve.
方法:回顾性分析失代偿期乙肝后肝硬化患者的临床资料,以患者出院时生存或死亡为结果变量,以入院时的肝功能、肾功能、血电解质、血细胞分析、凝血功能等实验室检查结果,B超,食管胃底静脉曲张破裂出血,肝性脑病及腹水为自变量,进行单因素和多因素Logistic回归分析,得到多元回归方程变形后建立数学模型,预测患者的临床结局,并运用ROC曲线与CTP评分、MELD评分比较,评价其预测效率。
6) MELD scoring
MELD评分
1.
Application of MELD scoring system on evaluating cirrhosis bleeding from esophageal varices
MELD评分对肝硬化食管胃底静脉曲张出血的评估价值
2.
Conclusion:The MELD scoring system may accurately predict the short-term prognosis for patients who suffer from decompensated liver cirrhosis for no more than 1 year.
方法:对92例失代偿期乙型肝炎肝硬化住院患者中医药参与治疗后进行MELD评分。
补充资料:Meldrum's acid
分子式:C6H8O4
分子量:144.13
CAS号:2033-24-1
性质:熔点92-96°C。水溶性2.5 g/100 mL (20°C)。
分子量:144.13
CAS号:2033-24-1
性质:熔点92-96°C。水溶性2.5 g/100 mL (20°C)。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条